Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
NCT ID: NCT07007156
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
199 participants
OBSERVATIONAL
2025-06-12
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of ICU-VTE Scale in ICU Patients
NCT05487066
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180
Outcomes of Early Palliative Care Intervention for High-Risk Patients in the Intensive Care Unit-A Pilot Study
NCT04487054
Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
NCT03617796
Fluid Balance and Body Weight Changes in Critically Ill Adult Patients
NCT04434079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NECPAL positive
This group has a positive result for NECPAL scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to the ICU of the study center.
* Legal capacity to provide informed consent.
* Signed informed consent for study inclusion, either by the participant or their legal representative.
Exclusion Criteria
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari de l'Alt Penedès i Garraf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diana Gutiérrez, MD
Role: PRINCIPAL_INVESTIGATOR
CSAPG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CSAPG
Sant Pere de Ribes, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSAPG-74
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.